Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide

Clinical trial NCT06361264 · UNKNOWN

Trial details

NCT number: NCT06361264
Sponsor: KARANAHAN
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Stage IV Breast Cancer

Start date: 2018-11-01
Primary completion: 2024-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.